We fund research that explores how risk factors such as smoking, poor nutrition, and lack of physical activity can affect your risk of cancer.
The value must be greater than or equal to $5
The value must be lesser than $1M
Your gift is 100% tax deductible.
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Neurofibromatosis type 2 (NF2-related schwannomatosis) is a genetic condition that causes tumors to grow around nerves, often in the brain and spine. These tumors are usually non-cancerous (benign). But because of where they grow, they can cause serious problems and may need to be treated with surgery or radiation therapy.
NF2, also known as NF2-related schwannomatosis, is a genetic condition that causes tumors to grow around nerves. These tumors are often non-cancerous (benign), commonly found in the brain and spine.
NF2 symptoms can vary from person to person. Symptoms of NF2 can include:
NF2 is caused by a change (mutation) in a gene called NF2. The NF2 gene, located on chromosome 22, makes a protein called merlin (also known as schwannomin). Merlin is a tumor suppressor protein and helps control cell growth. When NF2is mutated, it can no longer make normal merlin, which allows tumors to form.
Approximately 50% of NF2 cases are inherited from a parent, while the other 50% of cases arise from spontaneous mutation in the NF2 gene.
NF2 is rare and affects about 1 in 25,000 people worldwide.
NF2 can be diagnosed by looking at symptoms, family history, imaging tests, and genetic testing. These include:
Most tumors in NF2 are non-cancerous (benign), but because of where they grow, they can cause serious problems, such as pain, weakness, and numbness. Rarely, these tumors can become cancerous.
There is no cure for NF2, but regular check-ups and treatments can help manage symptoms and complications.
Treatment depends on the type and location of the tumor:
If you or a family member has NF2, you might want to ask your doctor:
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
American Association of Neurological Surgeons (AANS). Neurofibromatosis: Overview. 2024. Accessed at https://www.aans.org/patients/conditions-treatments/neurofibromatosis/ on February 13, 2025.
Children's Tumor Foundation. What is NF2?. 2023. Accessed at https://www.ctf.org/nf2/ on February 13, 2025.
Genetic and Rare Diseases Information Center (GARD)/National Institutes of Health. Neurofibromatosis type 2. 2024. Accessed at https://rarediseases.info.nih.gov/diseases/7193/neurofibromatosis-type-2 on February 13, 2025.
Evans DGR et al. Advances in neurofibromatosis type 2 management. Journal of Medical Genetics, 2025;62(1):123–130.
National Cancer Institute. Neurofibromatosis and tumor risks. 2023. Available at https://www.cancer.gov
National Institute of Neurological Disorders and Stroke/National Institutes of Health. Neurofibromatosis fact sheet. 2023. Accessed at https://www.ninds.nih.gov/health-information/disorders/neurofibromatosis on February 13, 2025.
Last Revised: February 13, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.